Published in Ann Rheum Dis on October 28, 2014
Association between Psoriasis Vulgaris and Coronary Heart Disease in a Hospital-Based Population in Japan. PLoS One (2016) 1.40
Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink. J Invest Dermatol (2015) 0.98
Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study. Arterioscler Thromb Vasc Biol (2015) 0.96
Characteristics of rheumatoid arthritis and its association with major comorbid conditions: cross-sectional study of 502 649 UK Biobank participants. RMD Open (2016) 0.83
The Epidemiology of Psoriatic Arthritis. Rheum Dis Clin North Am (2015) 0.83
Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation? Ann Rheum Dis (2014) 0.83
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis (2016) 0.81
Prerace aspirin to protect susceptible runners from cardiac arrest during marathons: is opportunity knocking? Open Heart (2015) 0.79
Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3. J Invest Dermatol (2015) 0.79
Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatol Int (2016) 0.78
Parental rheumatoid arthritis and long-term child morbidity: a nationwide cohort study. Ann Rheum Dis (2015) 0.78
National Heart, Lung, and Blood Institute Working Group Report on Salt in Human Health and Sickness: Building on the Current Scientific Evidence. Hypertension (2016) 0.78
High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound. Rheumatol Int (2016) 0.77
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by. J Clin Aesthet Dermatol (2016) 0.77
Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study. Clin Rheumatol (2016) 0.76
Secukinumab sustains improvement in signs and symptoms of patients with active ankylosing spondylitis through 2 years: Results from a phase 3 study. Arthritis Care Res (Hoboken) (2017) 0.76
Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis. PLoS One (2016) 0.76
Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Patients With Psoriatic Arthritis Compared to Patients Without Psoriatic Arthritis. J Clin Rheumatol (2015) 0.76
Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review. Arch Dermatol Res (2017) 0.75
Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep (2016) 0.75
Comorbidities in Patients with Psoriatic Arthritis. Rambam Maimonides Med J (2017) 0.75
Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther (2017) 0.75
Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritis. Int J Clin Rheumtol (2015) 0.75
Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations. Ther Adv Musculoskelet Dis (2016) 0.75
Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey. PLoS One (2017) 0.75
Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study. Arthritis Care Res (Hoboken) (2016) 0.75
Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions. Dtsch Arztebl Int (2017) 0.75
Atherosclerosis in psoriatic disease: latest evidence and clinical implications. Ther Adv Musculoskelet Dis (2015) 0.75
The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study. PLoS One (2017) 0.75
Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts. Medicine (Baltimore) (2017) 0.75
Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study. Rheumatol Int (2016) 0.75
The preclinical phase of PsA: a challenge for the epidemiologist. Ann Rheum Dis (2017) 0.75
Psoriasis as a human model of disease to study inflammatory atherogenesis. Am J Physiol Heart Circ Physiol (2017) 0.75
Axial spondyloarthritis: the heart of the matter. Clin Rheumatol (2015) 0.75
The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis. Curr Atheroscler Rep (2017) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
The Read clinical classification. BMJ (1990) 15.83
Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med (2006) 14.72
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis (2010) 10.03
Risk of myocardial infarction in patients with psoriasis. JAMA (2006) 9.42
Purposeful selection of variables in logistic regression. Source Code Biol Med (2008) 6.18
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology (2007) 5.12
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J (2009) 3.93
The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf (2009) 3.36
Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. Arch Intern Med (2002) 3.24
Deaths: final data for 2009. Natl Vital Stat Rep (2011) 3.18
The risk of stroke in patients with psoriasis. J Invest Dermatol (2009) 2.97
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis (2011) 2.95
Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis (2012) 2.54
All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol (2003) 2.52
Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study. J Intern Med (2012) 2.39
Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J (2011) 2.30
Validation of death and suicide recording on the THIN UK primary care database. Pharmacoepidemiol Drug Saf (2009) 2.29
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther (2006) 2.28
Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiol Drug Saf (2013) 2.15
Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med (2008) 1.87
Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2008) 1.85
Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol (2011) 1.78
Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med (2008) 1.77
Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med (2010) 1.76
Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Pharmacoepidemiol Drug Saf (2010) 1.69
Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol (2013) 1.64
Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis (2012) 1.63
Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis (2008) 1.58
Rheumatoid arthritis in UK primary care: incidence and prior morbidity. Scand J Rheumatol (2009) 1.55
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol (2013) 1.50
High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis (2010) 1.35
Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network. Pharmacoepidemiol Drug Saf (2012) 1.34
Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study. Br J Dermatol (2012) 1.26
Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc (2013) 1.25
Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. Am J Med (2008) 1.16
Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) (2012) 1.15
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology (Oxford) (2013) 1.11
Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Ann Rheum Dis (2012) 1.08
Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network. Pharmacoepidemiol Drug Saf (2014) 1.04
Temporal and within practice variability in the health improvement network. Pharmacoepidemiol Drug Saf (2011) 1.01
Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. Ann Rheum Dis (2013) 1.01
Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study. J Eur Acad Dermatol Venereol (2012) 0.86
The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study. Ann Rheum Dis (2017) 0.75